Home Ad Exchange News Apple Music And Amazon’s Quid Pro Quo; Pfizer And Glaxo’s Bet On Consumer Health

Apple Music And Amazon’s Quid Pro Quo; Pfizer And Glaxo’s Bet On Consumer Health

SHARE:

Here’s today’s AdExchanger.com news round-up… Want it by email? Sign up here.

The Trillionaire Club

The campaign to promote Apple Music’s integration with Amazon Alexa-enabled devices is a biggie: top billing and a special tab for the Alexa app atop the App Store, promotions in the Apple Music app and push notifications to Apple Music subscribers. The push notification was a particularly aggressive move, writes MacStories, since promotional push notifications are against App Store guidelines. It’s a nice boost for Amazon, though. Apple is implying that integrating with Alexa is a core upgrade, like a developer update, rather than a marketing play. More. Apple and Amazon have been in an awkward dance lately. After years of frostiness, Apple became an official seller on Amazon last month, which gave Amazon a reason to squash third-party Apple product resellers. Although Amazon excludes HomePods, the Apple Music/Alexa partnership would still prove quite fruitful. Over the Thanksgiving holiday, Apple was the second-largest advertiser on Amazon (after Amazon, natch) and actually surpassed Amazon as the No. 1 brand for organic searches, according to data from the Amazon specialist ad tech company Downstream.

Take Your Medicine

GlaxoSmithKline and Pfizer will merge their consumer product divisions into a joint venture next year, with the British GlaxoSmithKline owning 68% and Pfizer owning the remainder. There’s also a plan to IPO within five years. If approved by shareholders, the joint venture will become the largest over-the-counter brand operator in the world, The New York Times reports. It’ll also transform two big fish into another true CPG brand whale. It makes sense for GSK and Pfizer to focus on their prescription drug businesses, which have higher growth potential and are increasingly divergent businesses, than to try and be consumer brand operators. Over-the-counter products such as vitamins and supplements, Advil, Nicorette, Tums and Aquafresh (all in the joint venture’s portfolio) face new competition from direct-to-consumer brands, whereas prescription meds seem like a safe bet. “But such concentration comes with risks, given that prescription drugs are costly to develop and are subject to boom-and-bust cycles in which consumer products can provide some insulation.” More.

Slap On The Wrist

Facebook and Google are being fined a collective $455,000 for violating campaign finance law in Washington. In June, the state accused both platforms of failing to keep proper records of who was buying campaign ads on their sites, The Washington Post reports. Google will pay $217,000 and Facebook will pay $238,000 for disobeying state law on political ad transparency. It’s less than a drop in the bucket for both companies, but also an indicator that regulators’ fuses are growing short. “Whether you are a small-town newspaper or a large corporation, Washington’s political advertising disclosure laws apply to everyone,” says Washington state Attorney General Bob Ferguson in a statement. More. Meanwhile, the District of Columbia filed a lawsuit on Wednesday against Facebook for violating consumer protection laws by misleading users about their data security during the Cambridge Analytica scandal. More at Bloomberg.

But Wait, There’s More!

You’re Hired!

Must Read

Comic: What Else? (Google, Jedi Blue, Project Bernanke)

Project Cheat Sheet: A Rundown On All Of Google’s Secret Internal Projects, As Revealed By The DOJ

What do Hercule Poirot, Ben Bernanke, Star Wars and C.S. Lewis have in common? If you’re an ad tech nerd, you’ll know the answer immediately.

shopping cart

The Wonderful Brand Discusses Testing OOH And Online Snack Competition

Wonderful hadn’t done an out-of-home (OOH) marketing push in more than 15 years. That is, until a week ago, when it began a campaign across six major markets to promote its new no-shell pistachio packs.

Google filed a motion to exclude the testimony of any government witnesses who aren’t economists or antitrust experts during the upcoming ad tech antitrust trial starting on September 9.

Google Is Fighting To Keep Ad Tech Execs Off the Stand In Its Upcoming Antitrust Trial

Google doesn’t want AppNexus founder Brian O’Kelley – you know, the godfather of programmatic – to testify during its ad tech antitrust trial starting on September 9.

Privacy! Commerce! Connected TV! Read all about it. Subscribe to AdExchanger Newsletters

How HUMAN Uncovered A Scam Serving 2.5 Billion Ads Per Day To Piracy Sites

Publishers trafficking in pirated movies, TV shows and games sold programmatic ads alongside this stolen content, while using domain cloaking to obscure the “cashout sites” where the ads actually ran.

In 2019, Google moved to a first-price auction and also ceded its last look advantage in AdX, in part because it had to. Most exchanges had already moved to first price.

Thanks To The DOJ, We Now Know What Google Really Thought About Header Bidding

Starting last week and into this week, hundreds of court-filed documents have been unsealed in the lead-up to the Google ad tech antitrust trial – and it’s a bonanza.

Will Alternative TV Currencies Ever Be More Than A Nielsen Add-On?

Ever since Nielsen was dinged for undercounting TV viewers during the pandemic, its competitors have been fighting to convince buyers and sellers alike to adopt them as alternatives. And yet, some industry insiders argue that alt currencies weren’t ever meant to supplant Nielsen.